Liver Tumors: New Technologies and New Managements

Los Angeles, California
Saturday, February 15, 2014

Liver Tumors: New Technologies and New Managements
Saturday, February 15, 2014 7:00 AM -
Sunday, February 16, 2014 1:10 PM (Pacific Time)

Cedars-Sinai Medical Center
(310) 423-5548
Advanced Health Sciences Pavilion
127 So. San Vicente Blvd.,Plaza Level PEC 6 - 7
Los Angeles, California 90048
United States

Map and Directions

Click here
to view conference brochure.

Course Description and Statement of Need

The management of patients with primary or metastatic liver tumors has changed dramatically in an astoundingly short time. Optimal patient management now demands input from well-informed individuals in a variety of specialty and subspecialty disciplines. Like never before, understanding and treating the complexities presented by such patients is a team endeavor requiring the clinician to maintain a current perspective on his/her role and the roles of others.

This two-day conference is intended for surgical oncologists, gastroenterologists, surgeons, primary care physicians and all other healthcare professionals who treat patients with primary or metastatic liver tumors. In addition to lecture format presentations, the course will include the following interactive instructional formats: debate and panel discussions, Q & A sessions, case discussions, and interactive video presentations. We are looking forward to providing you with the latest advances and future direction of the multidisciplinary management of common, unique and complex cases of liver tumors

Educational Objectives
  • Recognize the subtleties of underlying conditions and comorbidities among patients with hepatocellular carcinoma
  • For hepatocellular carcinoma, cholangiocarcinoma, colorectal tumors, and neuroendocrine tumors list the latest diagnostic modalities and describe the best approach to their employment.
  • Recognize and assess the full range of treatment options currently available for treating hepatocellular carcinomas, cholangiocarcinomas, colorectal tumors, and neuroendocrine tumors.
  • Identify strategies for the use of individual and combination therapies.
  • Evaluate the importance and utility of the multidisciplinary approach to the treatment of hepatocellular carcinomas, cholangiocarcinomas, colorectal tumors and neuroendocrine tumors.
  • Outline mechanisms of disease and the relevance to the future development of molecular-tailored diagnostic and treatment modalities for hepatocellular carcinomas, cholangiocarcinomas, colorectal tumors and neuroendocrine tumors.
  •  Analyze the new standards for determining the indications and contraindications for surgical intervention of cholangiocarcinomas, colorectal cancers, and neuroendocrine tumors.
  • Describe how combining treatment options for colorectal tumors can achieve successes that transcend any single modality. 
  • Assess the rationale and success of new, more aggressive treatment strategies for neuroendocrine tumors. 
   
Accreditation Statement
Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Cedars-Sinai Medical Center designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
California Board of Pharmacy accepts CE approved by Accreditation Council for Continuing Medical Education

Nurses
The California State Board of Registered Nursing accepts courses approved by the ACCME for category 1 credit as meeting the educational requirements for license renewal.
 

Contact Information

Payment Instructions

  • If you prefer to pay by check, please download the registration form by Clicking Here.